β-Lactams as promising anticancer agents: Molecular hybrids, structure activity relationships and potential targets

Eur J Med Chem. 2020 Sep 1:201:112510. doi: 10.1016/j.ejmech.2020.112510. Epub 2020 Jun 23.

Abstract

β-Lactam, commonly referred as azetidin-2-one, is a multifunctional building block for synthesizing β-amino ketones, γ-amino alcohols, and other compounds. Besides its well known antibiotic activity, this ring system exhibits a wide range of activities, attracting the attention of researchers. However, the structurally diverse β-lactam analogues as anticancer agents and their different molecular targets are poorly discussed. The purpose of this review is 3-fold: (1) to explore the molecular hybridization approach to design β-lactams hybrids as anticancer agents; (2) the structure activity relationship of the most active anticancer β-lactams and (3) to summarize their antitumor mechanisms.

Keywords: Anticancer mechanisms; Molecular hybridization approach; Structure activity relationship; β-Lactam.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Drug Design
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Molecular Structure
  • Structure-Activity Relationship
  • beta-Lactams / chemistry
  • beta-Lactams / pharmacology*

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • beta-Lactams